Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Medical Devices

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > FDA approving stem cell companies

<< Previous

Bullboard Posts

Next >>

Comment by MaterialWorldon Apr 04, 2020 3:17pm

140 Views

Post# 30879327

RE:FDA approving stem cell companies

Wow. Could'nt come at a better time for the COVID-19 infected people of the world. If we don't see upward movement in share price on Monday, we'll know for sure level 3 set algorithms are in full control, not free markets. GLTA MW

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season